{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:52Z","timestamp":1788754132020,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tracking the spread of invasive meningococcal disease (IMD) in the United States is important for identifying risk factors and devising public health strategies to prevent infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The epidemiology of IMD in the United States before, during, and after the COVID-19 pandemic (2016\u20132024) was assessed using surveillance data from the National Notifiable Diseases Surveillance System (NNDSS) and the Enhanced Meningococcal Disease Surveillance program (EMDS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IMD case numbers declined during the pandemic (2020\u20132021) to 208 in 2021 but rebounded to 312 in 2022 and have continued to increase through 2024 (provisionally 477 cases). In 2022, serogroup C was the predominant serogroup (107 cases), followed by serogroup B (61 cases). Except during the pandemic, IMD cases were higher among those attending versus not attending college. During and after the pandemic, groups with the highest IMD incidence were those &amp;lt;1\u202fyear of age (range, 0.38\u20130.56 cases per 100,000 persons) and within the Black population (range, 0.09\u20130.19 cases per 100,000 persons). The percentage of IMD cases occurring after the pandemic in men who have sex with men and those with HIV increased substantially from during the pandemic. The percentage of IMD cases that occurred among people experiencing homelessness (PEH) was relatively high, ranging from 2.4\u20136.3%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The data indicate a rebound in IMD after the COVID-19 pandemic, highlighting the importance of strengthening surveillance and vaccination among high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1694023","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:03:18Z","timestamp":1772607798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology of invasive meningococcal disease in the United States: review of recent data and identified risk factors"],"prefix":"10.3389","volume":"14","author":[{"given":"Jessica","family":"Presa","sequence":"first","affiliation":[{"name":"US Medical Affairs, Vaccines and Antivirals, Pfizer Inc","place":["Collegeville, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Spitz","sequence":"additional","affiliation":[{"name":"US Medical Affairs, Vaccines and Antivirals, Pfizer Inc","place":["Collegeville, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Balmer","sequence":"additional","affiliation":[{"name":"US Medical Affairs, Vaccines and Antivirals, Pfizer Inc","place":["Collegeville, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Snow","sequence":"additional","affiliation":[{"name":"US Medical Affairs, Vaccines and Antivirals, Pfizer Inc","place":["Collegeville, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Dooling","sequence":"additional","affiliation":[{"name":"US Medical Affairs, Vaccines and Antivirals, Pfizer Inc","place":["Collegeville, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","article-title":"Clinical recognition of meningococcal disease in children and adolescents","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","article-title":"Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review","volume":"22","author":"Shen","year":"2022","journal-title":"BMC Public Health"},{"key":"ref3","year":"2025"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1017\/s0950268823000328","article-title":"Epidemiology of invasive meningococcal disease worldwide from 2010\u20132019: a literature review","volume":"151","author":"Pardo de Santayana","year":"2023","journal-title":"Epidemiol Infect"},{"key":"ref5","year":"2024"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jinf.2022.10.022","article-title":"Meningococcal disease in North America: updates from the global meningococcal initiative","volume":"85","author":"Asturias","year":"2022","journal-title":"J Infect"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/microorganisms8101521","article-title":"Vaccines against meningococcal diseases","volume":"8","author":"Pizza","year":"2020","journal-title":"Microorganisms"},{"key":"ref9","year":"2025"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1086\/648963","article-title":"Epidemiologic profile of meningococcal disease in the United States","volume":"50","author":"Harrison","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref11","year":"2025"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.15585\/mmwr.mm6738a4","article-title":"Meningococcal disease surveillance in men who have sex with men - United States, 2015-2016","volume":"67","author":"Bozio","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","year":"2024"},{"key":"ref14","year":"2024"},{"key":"ref15","year":"2025"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.15585\/mmwr.mm7305a2","article-title":"Selection of antibiotics as prophylaxis for close contacts of patients with meningococcal disease in areas with ciprofloxacin resistance - United States, 2024","volume":"73","author":"Berry","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref17","year":"2025"},{"key":"ref18","year":"2025"},{"key":"ref19","author":"Rubis","year":"2025"},{"key":"ref20","year":"2024"},{"key":"ref21","year":"2024"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"ofad696","DOI":"10.1093\/ofid\/ofad696","article-title":"Meningococcal disease in persons with HIV reported through active surveillance in the United States, 2009\u20132019","volume":"11","author":"Rudmann","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.15585\/mmwr.mm7224a4","article-title":"Notes from the field: increase in meningococcal disease among persons with HIV - United States, 2022","volume":"72","author":"Rubis","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref24","year":"2024"},{"key":"ref25","year":"2024"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1016\/S2589-7500(23)00108-5","article-title":"Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS consortium","volume":"5","author":"Shaw","year":"2023","journal-title":"Lancet Digit Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/14760584.2024.2329618","article-title":"The important lessons lurking in the history of meningococcal epidemiology","volume":"23","author":"Borrow","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/pathogens14100962","article-title":"A ten-year retrospective review of medical records of patients admitted with meningitis or encephalitis at five hospitals in the United States highlights the potential for under-ascertainment of invasive meningococcal disease","volume":"14","author":"Ramirez","year":"2025","journal-title":"Pathogens"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s11739-023-03466-7","article-title":"MAGLIO study: epidemiological analysis on invasive meningococcal disease in Italy: focus on hospitalization from 2015 to 2019: comment","volume":"19","author":"Famularo","year":"2024","journal-title":"Intern Emerg Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2022.03.032","article-title":"Risk factors for contracting invasive meningococcal disease and related mortality: a systematic literature review and meta-analysis","volume":"119","author":"Dubey","year":"2022","journal-title":"Int J Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pmedr.2018.10.023","article-title":"A qualitative exploration of facilitators and barriers to meningitis vaccination uptake among men who have sex with men","volume":"13","author":"Johnson","year":"2019","journal-title":"Prev Med Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1186\/s12889-024-19740-y","article-title":"Public health management of invasive meningococcal disease outbreaks: worldwide 1973\u20132018, a systematic review","volume":"24","author":"Morello","year":"2024","journal-title":"BMC Public Health"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3201\/eid3004.231392","article-title":"Concurrent outbreaks of hepatitis A, invasive meningococcal disease, and Mpox, Florida, USA, 2021-2022","volume":"30","author":"Doyle","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e228573","DOI":"10.1001\/jamanetworkopen.2022.8573","article-title":"Meningococcal vaccination rates among people with a new diagnosis of HIV infection in the US","volume":"5","author":"Ghaswalla","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1093\/infdis\/jiac230","article-title":"Invasive meningococcal disease among people experiencing homelessness-United States, 2016\u20132019","volume":"226","author":"Rudmann","year":"2022","journal-title":"J Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e0293070","DOI":"10.1371\/journal.pone.0293070","article-title":"Differences in meningococcal disease incidence by health insurance type and among persons experiencing homelessness-United States, 2016\u20132019","volume":"18","author":"Isenhour","year":"2023","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/14760584.2022.2052048","article-title":"Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease","volume":"21","author":"Taha","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCTB46","volume-title":"Strategies to address racial and ethnic disparities in health and healthcare: an evidence map (technical brief, no. 46) [internet]","author":"Lamina","year":"2024"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/vaccines11020256","article-title":"The impact of social determinants of health on meningococcal vaccination awareness, delivery, and coverage in adolescents and young adults in the United States: a systematic review","volume":"11","author":"Masaquel","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1186\/s12889-020-09181-8","article-title":"Parental awareness and utilization of meningococcal serogroup B vaccines in the United States","volume":"20","author":"Srivastava","year":"2020","journal-title":"BMC Public Health"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/14760584.2023.2211163","article-title":"Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions","volume":"22","author":"Ballalai","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1741-7015-10-160","article-title":"Passive smoking, invasive meningococcal disease and preventive measures: a commentary","volume":"10","author":"Rashid","year":"2012","journal-title":"BMC Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","article-title":"Tobacco product use among adults - United States, 2021","volume":"72","author":"Cornelius","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.15585\/mmwr.mm7244a1","article-title":"Tobacco product use among U.S. middle and high school students - national youth tobacco survey, 2023","volume":"72","author":"Birdsey","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/thoraxjnl-2018-211663","article-title":"Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages","volume":"73","author":"Scott","year":"2018","journal-title":"Thorax"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"19035","DOI":"10.1038\/s41598-019-51643-6","article-title":"E-cigarette flavored pods induce inflammation, epithelial barrier dysfunction, and DNA damage in lung epithelial cells and monocytes","volume":"9","author":"Muthumalage","year":"2019","journal-title":"Sci Rep"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1165\/rcmb.2020-0164OC","article-title":"Electronic-cigarette use alters nasal mucosal immune response to live-attenuated influenza virus. A clinical trial","volume":"64","author":"Rebuli","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref49","year":"2023"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1694023\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:03:19Z","timestamp":1772607799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1694023\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":49,"alternative-id":["10.3389\/fpubh.2026.1694023"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1694023","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1694023"}}